1389 related articles for article (PubMed ID: 1605145)
1. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.
Staub JJ; Althaus BU; Engler H; Ryff AS; Trabucco P; Marquardt K; Burckhardt D; Girard J; Weintraub BD
Am J Med; 1992 Jun; 92(6):631-42. PubMed ID: 1605145
[TBL] [Abstract][Full Text] [Related]
2. Episodic variations of prolactin, thyroid-stimulating hormone, luteinizing hormone, melatonin and cortisol in infertile women with subclinical hypothyroidism.
Bals-Pratsch M; De Geyter C; Müller T; Frieling U; Lerchl A; Pirke KM; Hanker JP; Becker-Carus C; Nieschlag E
Hum Reprod; 1997 May; 12(5):896-904. PubMed ID: 9194636
[TBL] [Abstract][Full Text] [Related]
3. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
Sarne DH; Sobieszczyk S; Ain KB; Refetoff S
J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
[TBL] [Abstract][Full Text] [Related]
4. Impaired action of thyroid hormone associated with smoking in women with hypothyroidism.
Müller B; Zulewski H; Huber P; Ratcliffe JG; Staub JJ
N Engl J Med; 1995 Oct; 333(15):964-9. PubMed ID: 7666915
[TBL] [Abstract][Full Text] [Related]
5. Prolactin and TSH response to TRH and metoclopramide before and after l-thyroxine therapy in subclinical hypothyroidism.
Lombardi G; Iodice M; Miletto P; Merola B; Panza N; Annunziato L
Neuroendocrinology; 1986; 43(6):676-8. PubMed ID: 3093910
[TBL] [Abstract][Full Text] [Related]
6. Thyroxine replacement therapy and circulating lipid concentrations.
Franklyn JA; Daykin J; Betteridge J; Hughes EA; Holder R; Jones SR; Sheppard MC
Clin Endocrinol (Oxf); 1993 May; 38(5):453-9. PubMed ID: 8330440
[TBL] [Abstract][Full Text] [Related]
7. LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease.
Althaus BU; Staub JJ; Ryff-De Lèche A; Oberhänsli A; Stähelin HB
Clin Endocrinol (Oxf); 1988 Feb; 28(2):157-63. PubMed ID: 3168304
[TBL] [Abstract][Full Text] [Related]
8. Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6.
Siemińska L; Wojciechowska C; Walczak K; Borowski A; Marek B; Nowak M; Kajdaniuk D; Foltyn W; Kos-Kudła B
Endokrynol Pol; 2015; 66(5):394-403. PubMed ID: 26457493
[TBL] [Abstract][Full Text] [Related]
9. Effect of prolonged oral administration of TRH on plasma levels of thyrotrophin and prolactin in normal individuals and in patients with primary hypothyroidism.
Frey HM; Haug E
Acta Endocrinol (Copenh); 1977 Aug; 85(4):744-52. PubMed ID: 407759
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein cholesterol in subclinical hypothyroidism.
Vierhapper H; Nardi A; Grösser P; Raber W; Gessl A
Thyroid; 2000 Nov; 10(11):981-4. PubMed ID: 11128726
[TBL] [Abstract][Full Text] [Related]
11. Disturbed lipid metabolism in patients with subclinical hypothyroidism: effect of L-thyroxine therapy.
Miura S; Iitaka M; Yoshimura H; Kitahama S; Fukasawa N; Kawakami Y; Sakurai S; Urabe M; Sakatsume Y; Ito K
Intern Med; 1994 Jul; 33(7):413-7. PubMed ID: 7949641
[TBL] [Abstract][Full Text] [Related]
12. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment.
Tzotzas T; Krassas GE; Konstantinidis T; Bougoulia M
Thyroid; 2000 Sep; 10(9):803-8. PubMed ID: 11041458
[TBL] [Abstract][Full Text] [Related]
13. Influence of thyroid status on the paradoxical growth hormone response to thyrotropin-releasing hormone in human obesity.
Coiro V; Volpi R; Capretti L; Speroni G; Marchesi C; Vescovi PP; Caffarri G; Colla R; Rossi G; Davoli C
Metabolism; 1994 Apr; 43(4):514-7. PubMed ID: 8159113
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for cardiovascular disease in women with subclinical hypothyroidism.
Luboshitzky R; Aviv A; Herer P; Lavie L
Thyroid; 2002 May; 12(5):421-5. PubMed ID: 12097204
[TBL] [Abstract][Full Text] [Related]
15. Modulation of human thyrotropin oligosaccharide structures--enhanced proportion of sialylated and terminally galactosylated serum thyrotropin isoforms in subclinical and overt primary hypothyroidism.
Trojan J; Theodoropoulou M; Usadel KH; Stalla GK; Schaaf L
J Endocrinol; 1998 Sep; 158(3):359-65. PubMed ID: 9846165
[TBL] [Abstract][Full Text] [Related]
16. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
Iqbal A; Jorde R; Figenschau Y
J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
[TBL] [Abstract][Full Text] [Related]
17. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
[TBL] [Abstract][Full Text] [Related]
18. Thyroid-stimulating hormone, prolactin, and growth hormone response to thyrotropin-releasing hormone in treated children with congenital hypothyroidism.
Sack J; Shafrir Y; Urbach D; Amado O
Pediatr Res; 1985 Oct; 19(10):1037-9. PubMed ID: 3932951
[TBL] [Abstract][Full Text] [Related]
19. Effect of dexamethasone on TSH secretion induced by TRH in human obesity.
Coiro V; Volpi R; Capretti L; Speroni G; Pilla S; Cataldo S; Bianconcini M; Bazzani E; Chiodera P
J Investig Med; 2001 Jul; 49(4):330-4. PubMed ID: 11478409
[TBL] [Abstract][Full Text] [Related]
20. Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?
Efstathiadou Z; Bitsis S; Milionis HJ; Kukuvitis A; Bairaktari ET; Elisaf MS; Tsatsoulis A
Eur J Endocrinol; 2001 Dec; 145(6):705-10. PubMed ID: 11720894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
